XADAGO FDA approval date

The FDA approved XADAGO on 21 Mar 2017.

FDA approval date
21 Mar 2017

Drug identity has not yet been verified against registry records

Also recorded as SAFINAMIDE MESYLATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2017-03-21DayXADAGOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207145", "applicant_as_listed_by_fda": "MDD US", "brand_names": ["XADAGO"], "active_ingredients": ["SAFINAMIDE MESYLATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20170321", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026